PS Ratio
1.03
+0.01+0.98%
Thu, 28 Nov 2024 00:56:32 GMT
Summary:
Adaptimmune Therapeutics price to sales ratio is currently 1.03, with a rise of +0.01 (+0.98%) during the most recent trading day. Over the past year, it has dropped by -0.41 (-28.47%). ADAP PS ratio is now -99.89% below its all-time high of 929.61.ADAP PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP PS Ratio Performance
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | +1.0% | +1.4% | +1.4% | +23.7% |
1 m1 month | -6.4% | -6.1% | -6.0% | - |
3 m3 months | -53.4% | -42.0% | -42.0% | - |
6 m6 months | -92.8% | -31.3% | -31.2% | - |
ytdytd | -65.4% | -10.5% | +0.8% | - |
1 y1 year | -28.5% | +57.0% | +76.8% | +146.3% |
5 y5 years | -98.1% | -25.9% | +80.2% | +9245.5% |
ADAP PS Ratio High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 1.22 | -15.6% | 0.88 | +17.1% |
3 m | 3 months | 2.33 | -55.8% | 0.88 | +17.1% |
6 m | 6 months | 15.45 | -93.3% | 0.88 | +17.1% |
1 y | 1 year | 21.71 | -95.3% | 0.88 | +17.1% |
3 y | 3 years | 103.99 | -99.0% | 0.88 | +17.1% |
5 y | 5 years | 929.61 | -99.9% | 0.88 | +17.1% |
alltime | all time | 929.61 | -99.9% | 0.88 | +17.1% |
Adaptimmune Therapeutics PS Ratio History
Date | Value |
---|---|
2024 | 1.03(-65.4%) |
2023 | 2.98(-65.8%) |
2022 | 8.72(-90.8%) |
2021 | 95.29(-54.8%) |
2020 | 210.80(+87.4%) |
Date | Value |
---|---|
2019 | 112.48(+1012.6%) |
2018 | 10.11(-38.9%) |
2017 | 16.54(-18.1%) |
2016 | 20.19(-85.3%) |
2015 | 137.51 |
FAQ
- What is Adaptimmune Therapeutics price to sales ratio?
- What is the all time high PS ratio for Adaptimmune Therapeutics?
- What is ADAP price to sales ratio year-to-date change?
- What is Adaptimmune Therapeutics PS ratio year-on-year change?
What is Adaptimmune Therapeutics price to sales ratio?
The current PS ratio of ADAP is 1.03
What is the all time high PS ratio for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high price to sales ratio is 929.61
What is ADAP price to sales ratio year-to-date change?
Adaptimmune Therapeutics price to sales ratio has changed by -1.95 (-65.44%) since the beginning of the year
What is Adaptimmune Therapeutics PS ratio year-on-year change?
Over the past year, ADAP price to sales ratio has changed by -0.41 (-28.47%)